American White Cross
This article was originally published in The Gray Sheet
Executive Summary
Plans secondary offering of 2,750,000 shares of common stock (2.5 mil. to be offered by the company and 250,000 by selling shareholder National Patent Medical, a subsidiary of National Patent Development Corp.), according to a prospectus filed with the Securities and Exchange Commission. The Dayville, Connecticut manufacturer and marketer of bandages and other health care products anticipates using proceeds of approximately $18.6 mil. ($21.8 mil. if the underwriters overallotment option is exercised) to repay certain debts totaling $20.2 mil. as of Feb. 28. Nearly half of the debt resulted from the May 1993 acquisition of American White Cross Laboratories by NPM Healthcare Products, which changed its name to American White Cross on March 3. Oppenheimer & Co., Advest and Mabon Securities are underwriters for the offering
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.